Study of Dexmedetomidine as an Effective Sedative to Treat Acute ICU Delirium

Trial Profile

Study of Dexmedetomidine as an Effective Sedative to Treat Acute ICU Delirium

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Jun 2017

At a glance

  • Drugs Dexmedetomidine (Primary)
  • Indications Delirium
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Mar 2017 Status changed from active, no longer recruiting to completed.
    • 11 May 2010 Planned number of patients (130) added as reported by ClinicalTrials.gov record.
    • 11 May 2010 Planned end date (1 Sep 2011) added as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top